Prominent Indian American Cancer Scientists Awarded Scientific Excellence Awards

Prominent Indian American Cancer Scientists Awarded Scientific Excellence Awards

By India New England News

BOSTON–The 29th AAISCR annual meeting was held virtually recently. The meeting was attended by many eminent cancer research scientists including young investigators of Indian origin, biotechnology company representatives, and representatives from the prestigious American Association for Cancer Research (AACR).

Dr. Aniruddha Ganguly, Founder and current President addressed the AAISCR community by emphasizing the importance of supporting the community of Indian American cancer researchers for the last 29 years with integrity, loyalty and generosity. Most of the AAISCR members developed friendship and research collaborations through AAISCR. This organization best serves by connecting scientists of similar interest to help them develop network, pursue common goals, share knowledge and expertise, provide information on cancer education and training, mentoring scientists at different career levels, provide scholarships for scientific meeting travel, training, and seed funds for developing new projects, recognize outstanding scientific achievements through a variety of award mechanisms, and provide opportunity to get current information on funding and training offered by the National Institutes of Health.

This year AAISCR Lifetime Achievement Awards were presented to two renowned scientists who have made significant fundamental contributions to cancer research including treatment, either through a single scientific discovery or a body of research work and have had a lasting impact on cancer research and demonstrated a lifetime commitment to the progress against cancer.

The keynote speaker and lifetime achievement awardee Dr. Arul Chinnaiyan is S.P. Hicks Endowed Professor of Pathology, Director, Michigan Center for Translational Pathology, investigator, Howard Hughes Medical Institute, American Cancer Society Research Professor and Professor of Urology at the University of Michigan. Dr. Chinnaiyan is elected member of the American Academy of Arts and Sciences, the Institute of Medicine of the National Academy of Sciences, the Association of American Physicians and the American Society for Clinical Investigation. Dr. Chinnaiyan is best known for the discovery of TMPRSS2-ETS gene fusions in prostate cancers, the first causative gene fusion in a common solid tumor. These gene fusions are specific markers of prostate cancer. This discovery was made using a bioinformatics approach to detect outlier genes in an aggregated tumor gene expression database called ONCOMINE, developed by his group.

AAISCR awards are testaments of scientific excellence that help promote career development, and mark distinction in scientific careers. AAISCR recognizes high quality reproducible research that may become meaningful to cancer researchers.

Read the rest @


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *